Biotech Archives - Page 777 of 795

1 minute read

WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years

July 18, 12:38 PM

According to the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO), approximately 25 million children worldwide missed routine…

AZN

1 minute read

FDA
News

Neuronetics Receives FDA 510(k) Premarket Notification Clearance For The Neurostar TMS Therapy System For Mental Health

By Benzinga Newsdesk

July 18, 11:26 AM

accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K220127

STIM

1 minute read

FDA
News

European Medicines Agency Says Started Evaluating The Use Of Pfizer’s Comirnaty In Children Aged 6 Months To 4 Years

By Benzinga Newsdesk

July 18, 11:24 AM

-Reuters

PFE

1 minute read

AbbVie To Submit European Application For Epcoritamab In Lymphoma Setting Later In 2022

By Vandana Singh

July 18, 11:05 AM

Genmab A/S (NASDAQ:GMAB) has announced that AbbVie Inc (NASDAQ:ABBV) will submit a conditional marketing authorization application with the European Medicines Agency…

ABBV

1 minute read

FDA
News

AstraZeneca Says Vaxzevria 73% Effective At Preventing Omicron-related Infections After Fourth Dose, According To Real World Evidence Study In Thailand

By Benzinga Newsdesk

July 18, 11:03 AM

-Reuters

AZN

1 minute read

Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study

By Vandana Singh

July 18, 11:02 AM

Algernon Pharmaceuticals Inc (OTC:AGNPF) has announced topline data showing that it has met the co-primary endpoint in its Phase 2 proof…

AGNPF

1 minute read

PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors

By Vandana Singh

July 18, 10:47 AM

PMV Pharmaceuticals Inc (NASDAQ:PMVP) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK) to evaluate PC14586…

MRK

1 minute read

Apyx Medical’s Renuvion Scores FDA Approval To Eliminate Sagging Neck

By Vandana Singh

July 18, 10:40 AM

The FDA has granted 510(k) clearance for Apyx Medical Corporation’s (NASDAQ:APYX) Renuvion for subcutaneous dermatological and aesthetic procedures to improve the appearance…

APYX

1 minute read